IL6 and Sepsis: In experimental models, genetic or pharmacological inhibition of CD38 attenuated pro-inflammatory cytokine production (e.g., IL-6, CXCL1), improved survival in cecal ligation and puncture (CLP)-induced sepsis, and mitigated multi-organ dysfunction.